跳至主要内容
临床试验/JPRN-jRCT1090220159
JPRN-jRCT1090220159已完成Unknown

Study of Breast Reconstruction with Adipose tissue-derived mesenchymal stem cells (ADSCs) in the Treatment of Patients with Breast Deformities Post-breast Conservation Therapy

Rie Yamashita0 个研究点目标入组 5 人开始时间: 2014年1月8日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 至 ot applicable(—)
性别
Female

入选标准

  • (1) Female with Breast Deformities Post-breast Conservation Therapy
  • (2) Surgical operation, endoscopic surgery or segmental mastectomy
  • (3)Clean surgical margins
  • (4)Presence of sufficient fat volume to liposuction
  • (5)No use of an artificial breast
  • (6)No recurrence of cancer and cancer metastasis 12 months prior to enrollment
  • (7)No evidence of recurrence of cancer in based on Mammogram or MRI prior to enrollment
  • (8)No history of cancer targeted chemotherapy (except estrogen replacement therapy) in the 12 months preceding enrollment.
  • (9)A minimum of 1cm soft tissue is available between skin and breast
  • (10)A minimum of 2/3 of the breast is remaining post breast conservation therapy.
  • (11)No continuous adhesions of skin to bone > 3cm in diameter
  • (12)The patient understand the clinical studies, she wishes to treatment and her consent is obtained

排除标准

  • (1)Presence or history of any other known malignancy within 5 years. Possibility of malignant tumors by checking examination.
  • (2)Current use of anti-cancer therapies or immunosuppressant
  • (3)Presence of infection disease
  • (4)Fever (above 38.5 degree)
  • (5)Presence of serious complications (such as poor control high blood pressure and diabetes, heart disease, lung disease, liver disease, kidney disease, or bleeding tendency )
  • (6)History of autoimmune disease
  • (7)History of keloid constitution
  • (8)Chronic use ( > 7 consecutive days) anticoagulants or NSAIDs within 15 days prior to enrollment.
  • (9)Life expectancy <= 2 years
  • (10)30 < Body Mass Index (BMI) < 18.5
  • (11)History of drug hypersensitivity
  • (12)Pregnancy, breastfeeding and/or possibility of pregnant
  • (13)Other, If the doctor (investigator) has to be inappropriate

研究者

发起方
Rie Yamashita

相似试验